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https://doi.org/10.1016/j.stemcr.2020.01.015SUMMARYAberrant neuronal development and the persistence of mitotic cellular populations have been implicated in a multitude of neurological
disorders, including Huntington’s disease (HD). However, the mechanism underlying this potential pathology remains unclear. We used
a modified protocol to differentiate induced pluripotent stem cells (iPSCs) from HD patients and unaffected controls into neuronal cul-
tures enriched for medium spiny neurons, the cell type most affected in HD. We performed single-cell and bulk transcriptomic and epi-
genomic analyses and demonstrated that a persistent cyclin D1+ neural stem cell (NSC) population is observed selectively in adult-onset
HD iPSCs during differentiation. Treatment with a WNT inhibitor abrogates this NSC population while preserving neurons. Taken
together, our findings identify a mechanism that may promote aberrant neurodevelopment and adult neurogenesis in adult-onset HD
striatal neurons with the potential for therapeutic compensation.INTRODUCTION
Huntington’s disease (HD) is an autosomal dominant CAG-
repeat neurodegenerative disease (Huntington’s Disease
Collaborative ResearchGroup, 1993).Mutation of the hun-
tingtin (HTT) gene results in an expanded polyglutamine
(Qn) repeat within the HTT (mHTT) protein. Individuals
with R40Q develop HD, with juvenile-onset cases before
age 20 years typically occurring above 60 repeats (Cronin
et al., 2019). HD symptoms include uncontrollable move-
ment, psychiatric disturbances, and cognitive impairment
(Tabrizi et al., 2019) with progressive neurodegeneration
and brain atrophy. The primary cell type that degenerates
ismedium spiny neurons (MSNs) of the striatum, and there
remain gaps in our knowledge of early and initiating events
in HD systems.
Due to the degenerative nature of HD, postmortem
human tissues limit our understanding of early neuropa-
thology of affected brain regions. Human induced pluripo-
tent stem cells (iPSCs) have emerged as important models
to study neurodegenerative disease mechanisms (Poon
et al., 2017). HD iPSCs differentiated to neural lineages
have elucidated deficits in axonal guidance, lipid meta-
bolism, and neuronal development and function (Conforti406 Stem Cell Reports j Vol. 14 j 406–419 j March 10, 2020 j ª 2020 The Au
This is an open access article under the CC BY-NC-ND license (http://creativet al., 2018; HD iPSCConsortium, 2017; The HD iPSCCon-
sortium, 2012), and dysregulation of the transforming
growth factor b (Bowles et al., 2017; Ring et al., 2015), wing-
less-related integration site (WNT) (Lim et al., 2017), and
p53 (Guo et al., 2013; Ring et al., 2015) signaling pathways.
Increased cell proliferation in HD patient brains propor-
tional to disease grade in the subependymal layer that over-
lies the degenerating caudate nucleus (Curtis et al., 2003,
2005) suggests increased neurogenesis in the adult brain,
potentially as an adaptation to disease. Using HD iPSC-
derived neuronal cultures and differentiated embryonic
stem cells (ESCs), dysregulation of neurodevelopmental
pathways implicates deficits in striatal maturation (Wiatr
et al., 2018). These signaling deficits occur early and are
associated with phenotypes such as increased vulnerability
to growth factor withdrawal in persistent neural progeni-
tors (Mattis et al., 2014; Ring et al., 2015), suggesting that
while neurogenesis is initiated, neuronal maturation may
be impaired, leaving developmentally arrested cells vulner-
able to cellular stressors. The mechanisms involved remain
undefined, and these studies have primarily centered on
highly expanded juvenile-onset repeat lines, with little
known about the more prevalent adult-onset repeat-
induced mechanisms.thor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
Here, we use a multi-omics approach to investigate
mHTT-associated molecular phenotypes using a modified
protocol to differentiate HD patient iPSCs into highly
pure populations of neurons with striatal characteristics.
RNA sequencing (RNA-seq) and chromatin immunoprecip-
itation sequencing (ChIP-seq) analysis reveal significant
dysregulation in cell-cycle-associated gene ontology (GO)
terms. We show the persistence of a cyclin D1+ mitotic
cellular population that emerges among neural progenitors
in adult-onset lines and is maintained through terminal
differentiation. Single-cell RNA-seq (scRNA-seq) confirms
that cell-cycle-related signaling cues arise from the mitotic
population of cells, identified as neural stem cells (NSCs),
rather than the striatal neurons present in the same popu-
lation. Furthermore, we show that the persistence of NSC
populations is the result of aberrant WNT signaling and
we can ameliorate this population through WNT inhibi-
tion. This perhaps identifies a pathway or mechanistic
target for future therapeutic exploration.RESULTS
Modified Protocol for Differentiation of iPSCs to Pure
Neurons for Epigenomic Study
Our goal was to define epigenetic signatures of neuronal
cultures enriched for MSNs. iPSCs were differentiated to
electrophysiologically active neurons (Arber et al., 2015;
Telezhkin et al., 2016) with the addition of activin A to
promote the formation of lateral ganglionic eminence
(LGE)-like progenitors and the subsequent systematic pro-
gramming of neural progenitors. Comparing the previous
protocol (referred to as LI, due to the media containing
LDN193189 and IWR1) (Telezhkin et al., 2016) to this pro-
tocol with addition of activin A (LIA = medium containing
LDN193189, IWR1, and activin A), we observe an increase
in the co-staining of Protein Phosphatase 1 Regulatory In-
hibitor Subunit 1B (PPP1R1B, alias DARPP-32) and B-cell
lymphoma/leukemia 11B (BCL-11B or CTIP-2) when tested
on 33Q control neuronal cultures without any noticeable
change to overall neuronal maturation, as seen using
phase-contrast microscopy. There is no change in the pro-
liferation of these cell lines at the neural progenitor day
16 stage (Figure S1). Four control lines (CS25iCTR18n2—
18Qn2, CS25iCTR18Qn6—18n6, CS14iCTR28n6—
28Qn6 [28Q], CS83iCTR33n1—33Qn1 [33Q]), two
adult-onset lines (CS04iHD46n10—46Qn10 [46Q]
and CS03iHD53n3—53Qn3 [53Q]), and three juvenile-
range repeat lines (CS02iHD66n4—66n4 [66Q],
CS81iHD71n3—71n3 [71Q], CS09iHD109n1—109n1
[109Q]) were differentiated over 37 days to mature
neuronal cultures in duplicate (18Qn2, 46Q) or triplicate
(18Qn6, 28Q, 33Q, 53Q, 66Q, 71Q, 109Q) (Figure 1). Qual-ity control measures were performed (Table S1). To control
for sex effects, these lines include male (18Q, 46Q, 53Q)
and female subjects (28Q, 33Q, 66Q, 71Q, 109Q). Mature
neurons were defined by microtubule-associated protein
2 (MAP-2) expression and striatal neurons by DARPP-32
and BCL-11B co-staining (Figure S2); quantification can
be found in Table S1. The 46Q iPSC line was the only
sample not to reach 10% DARPP-32 expression in the total
population following differentiation (Table S1). As this dif-
ferentiation protocol provides a high percentage of mature
neurons (79%–98%MAP-2+ for all cell lines), the following
data represent a multi-omics analysis of mature neuronal
cultures enriched for striatal characteristics derived from
iPSCs within the context of HD.
Transcriptomics Reveal anUpregulation of Cell-Cycle-
Related Genes in HD
Bulk, total RNA-seq was used to identify differentially ex-
pressed genes (DEGs) between control and HD mature
neuronal cultures enriched for MSNs. Gene expression
values and DEGs were used for principal component anal-
ysis (PCA), GO enrichment analysis (GOrilla) and Ingenu-
ity Pathway Analysis. Curiously, PCA of control (red) and
juvenile-repeat range (green) lines shows no clear separa-
tion (Figure S3). Only 105 DEGs were identified (Table S2,
columns A–H) when comparing highly expanded repeat
lines with controls, and there was no enrichment for
specific GO terms, although RE1 Silencing Transcription
Factor (REST) was downregulated as described in neural cul-
tures (Buckley et al., 2010; HD iPSC Consortium, 2017).
Finding limited DEGs was surprising given the docu-
mented transcriptional dysregulation in HD and in models
expressing juvenile-range repeat lengths (Valor, 2015).
Control (red) and adult-onset (blue) lines, however, show
separation along principal component 1 (PC1) (Figure 2A).
Given the statistical difference between the control and
adult-onset lines and the biological relevance of exploring
CAG-repeat lengths more prevalent in the HD population,
we continued our analysis to define transcriptional differ-
ences between control and adult-onset lines. We identified
823 DEGs in adult-onset neuronal cultures enriched for
MSNs compared with control lines (10% false discovery
rate [FDR] cutoff), with 754 genes upregulated and 69 genes
downregulated (Table S2, columns I–P). The top genes by
adjusted p value are labeled in a volcano plot (Figure 2B).
Interestingly, the secondmost statistically significantly up-
regulated gene was the pluripotency marker POU domain,
class 5, transcription factor 1 (POU5F1, alias Oct4) whereas
other markers of pluripotency were not dysregulated
(NANOG homeobox gene [NANOG], Podocalyxin like
[PODXL, alias TRA-1-81], Kruppel-like factor 4 [KLF4],
MYC proto-oncogene [MYC]). GO enrichment revealed
dysregulation of cell-cycle-associated biological processesStem Cell Reports j Vol. 14 j 406–419 j March 10, 2020 407
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Figure 1. Differentiation Protocol for iPSC-Derived Striatal Neuronal Cultures
(A) Schematic of the differentiation protocol used for iPSC-derived striatal neurons enriched for medium spiny neurons (MSNs) adapted
from Telezhkin et al. (2016).
(B) Representative immunofluorescence images of cells at day 37 in control (top) and HD (bottom) cells showing that the cells are positive
and co-localize for DARPP-32 and BCL-11B (left); cells are also positive for FOX-P1 and MAP-2 (middle) and are GABAergic, as they express
the glutamate decarboxylase-2 enzyme (right). Scale bar, 20 mm.(Figure 2C), DNA-binding-associated molecular functions
(Figure 2D), and chromosomal gene-associated cellular
components (Figure 2E). The top cellular function, pre-
dicted to be activated, is cell-cycle progression, with a
p value of 7.57 3 1039.
Upregulation of Cell-Cycle-Related Genes and
Transcription Factors in HD Identified Using
Epigenomic Analysis
WeperformedChIP-seq on trimethylated, histone 3 lysine 4
(H3K4me3) residues to identify active promoters in control
(18Qn2, 18Qn6, 28Q, 33Q) and HD (46Q, 53Q) neuronal
cultures, whereby 99,765 K4me3 sites were found across408 Stem Cell Reports j Vol. 14 j 406–419 j March 10, 2020the lines. Differential analysis of K4me3 occupancy between
control and HD lines identified 2,153 sites (5% FDR cutoff);
1,133 of the sites had higher K4me3 levels in HD and 764
sites had higher levels in controls. PCA of differential peaks
(Figure 3A) shows clear separation between control and HD
K4me3-enriched signals. Differential peaks were annotated
to 1,340 genes within a window of 10 kb from transcription
start sites (TSS), with a majority of the genes (1,143 genes)
having an upregulatedK4me3 signal inHD.GOenrichment
analysis of the genes annotated to thedifferential sites shows
enrichment of cell-cycle-related terms (Figure 3B).
We overlapped the ChIP-seq and RNA-seq differential
signals and found that almost half of the transcriptionally
Figure 2. Cell-Cycle-Related Genes Are Upregulated in HD Adult-Onset Cell Lines by RNA-Seq
(A) PCA of global gene expression in HD (46Q and 53Q) and control (18Q, 28Q, and 33Q) iPSC-derived striatal neurons. PC1, which captures
the most gene expression variance between samples, shows separation of HD and control samples.
(B) Volcano plot showing statistically significant DEGs (light blue) between HD (46Q and 53Q) and control (18Q, 28Q, and 33Q) samples.
The most significant genes, by FDR, are labeled. Significant gene expression differences are skewed, showing many more upregulated DEGs
in the HD samples (Table S2, columns A–H).
(C–E) Top GO enrichment analysis terms for biological process (C), molecular function (D), and cellular components (E) showing
enrichment for cell cycle, DNA binding, extracellular matrix, and chromosomal genes.upregulated genes in HD (327 DEGs) had K4me3-upregu-
lated sites in the area next to their TSS (Figure 3C). The
subset of genes upregulated both transcriptionally and
epigenetically show higher enrichment for cell-cycle GO
terms (compare Figures 3D and 3B). We used Assay for
Transposase-Accessible Chromatin sequencing (ATAC-
seq) data to localize the transcription factor (TF)-binding
sites within the K4me3 differential sites adjusted to the
upregulated DEGs. TF analysis of these sites suggests
enrichment for binding of several TFs related to cell-cycle
regulation in HD lines (Figure 3E).
Adult-Onset HD Cell Lines Have a Persistent
Mitotically Active Population in Neuronal Cultures
Additional adult-onset HD lines were added to the study
to determine whether the altered mitotic signature wasmaintained across different subjects. Within each of the
terminally differentiated adult-onset lines, we observe
novel populations comprising cells with enlarged cell
bodies that lack projections, which are quite distinct
from neurons and are absent in control cell lines (Fig-
ure 4A). These morphologically distinct cell clusters are
readily apparent at the end of culture, as identified by
phase-contrast microscopy. These cells are visible at low
frequency at day 18 and are observed at higher frequency
by day 23 among differentiating neurons. These cell clus-
ters are present in each of four adult-onset HD cell lines
examined (CS13iHD43n13 [43Q], 46Q, CS87iHD50n7—
50Qn7 [50Q], 53Q) by immunofluorescence and phase-
contrast microscopy (Figures S4A and S4B). These aberrant
cells are positive for the cell-cycle G1/S phase transition
marker cyclin D1, the pluripotency marker Oct4, andStem Cell Reports j Vol. 14 j 406–419 j March 10, 2020 409
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Figure 3. Epigenomics Upregulation of Cell-Cycle-Related Genes in HD
(A) PCA of K4me3 sites identified by ChIP-seq in HD (46Q and 53Q) and control (18Q, 28Q, and 33Q) iPSC-derived striatal neurons.
(B) Top GO enrichment analysis terms for genes near K4me3 differential sites show enrichment for cell cycle.
(C) Venn diagram of genes upregulated in HD in RNA-seq and ChIP-seq. Upregulated K4me3 sites were found near the TSS of almost half of
the transcriptionally upregulated genes in HD.
(D) Top GO enrichment analysis terms for the RNA and ChIP-seq overlapping genes show enrichment for cell-cycle processes.
(E) Transcription factor (TF) analysis of the regulatory sites near genes upregulated in both RNA and ChIP-seq. Cell-cycle-related
TF-binding sites are enriched in HD.the neuroectoderm marker nestin, and are negative for
the neuronal marker MAP-2 (Figure 4B), an unexpected
finding given that the differentiation protocol produces
terminally differentiated, post-mitotic, mature neurons.
This population is not the result of the LIA-adapted neural
progenitor specification adopted in our protocol, as it is
also observed using the previously published LI protocol
(Telezhkin et al., 2016) (Figures S1D and S4A), which is
important given the role that activin A can play in plurip-
otency (Beattie et al., 2005).410 Stem Cell Reports j Vol. 14 j 406–419 j March 10, 2020Flow cytometry was used to quantify the percentage of the
population composed of cyclin D1+ cells, which revealed a
significant increase (p = 0.0003) of cyclin D1+ cells
(48.46% ± 4.54%) in terminally differentiated HD lines
compared with controls (3.654% ± 1.206%) when grouped
together (Figure 4C). Separately, HD lines (50Q, 53Q) have
significantly more cyclin D1+ cells than controls (18Qn6
[18Q], CS71iCTR20n6—20Qn6 [20Q]) (Figure S4C). Almost
all of the cyclin D1+ cells were also nestin positive (98.5% ±
0.55%) and a high proportion of them were Oct4 positive
Figure 4. High Percentage of Adult-Onset HD Neuronal Populations Express Cyclin D1 Compared with Controls
(A) Phase-contrast images show control (top) and HD (bottom) neurons, with the mitotic population persisting in the HD line occupying
the majority of the field. Scale bar, 100 mm.
(B) Assessment of the cyclin D1+ population by immunofluorescence shows co-staining of cyclin D1 with nestin (top) and Oct4 (middle),
and no co-staining with MAP-2 (bottom). Scale bar, 20 mm. Images are representative of the four adult-onset lines tested (43Q, 46Q, 50Q,
53Q), quantification for which can be found in Figure S4A.
(C) Analysis of cyclin D1 expression by flow cytometry shows a significant increase in percentage of cells expressing cyclin D1 compared
with controls. Data were acquired across three experiments using three cell lines per condition for two experiments (18Q, 20Q, 33Q, 46Q,
50Q, 53Q) and one experiment with two lines per condition (18Q, 20Q, 50Q, 53Q). Data represent mean ± SEM. Unpaired one-tailed t test,
t = 9.539, df = 4, p = 0.0003, ***p < 0.001.
(D) Analysis of co-markers of HD cyclin D1+ cells by flow cytometry shows that the majority of cyclin D1+ cells are Oct4+ and nestin+. Data
from 50Q and 53Q (nestin), n = 1 HD cell line; data from 46Q, 50Q, 53Q (Oct4), n = 2 HD cell lines. Data represent mean ± SEM.(73.9% ± 14.1%) (Figure 4D), implying that Oct4 and nestin
are expressed in the same cells in a large proportion of the cy-
clin D1+ population. Of the total day-37 population, Oct4
was expressed at very low levels in control cells (1.03% ±
0.20%) and higher in adult-onset HD cells (22.7% ± 4.34%)
(Figure S5). Importantly, there was a very low percentage
(<0.054%: 20Q, 46Q, 50Q) of Oct4-positive cells in cultures
at early stages (day 8) (Figure S5). CyclinD1+ cells are prolifer-
ative throughout terminal differentiation, and increasingly
make up more of the total population as the number of
days in vitro progresses; however, this does not seem to have
a detrimental effect on the remaining post-mitotic neurons.
Single-Cell RNA-Seq Identifies the Cyclin D1+
Population Specific to Adult-Onset Lines as NSCs
To define the composition of the persistent cyclin D1+ cell
population present in HD cultures, we performed scRNA-seq on neuronal populations differentiated from one repre-
sentative control (18Qn6—18Q) and HD iPSC line (53Q).
Single-cell viability for each sample was determined
(86.9% for 18Q, 80.9% for 53Q). The estimated number
of cells sampled was 5,070 (18Q) and 3,829 (53Q) with
an average number of reads per cell of 31,675 (18Q) and
41,939 (53Q). After quality control of data filtering, the
data were aggregated using Cell Ranger and gene-by-cell
expression matrices generated and used as input for Seurat
and Scanpy. The top variable genes by PCA were used for
exploratory analysis and visualization using t-distributed
stochastic neighbor embedding (t-SNE) (Figure 5A). An un-
supervised clustering approach identified seven distinct
cell clusters, which were annotated using known cell-type
markers (Figure 5B and data not shown). The NSC cluster
(Figure 5A) is specific to the HD cell line, with the remain-
ing clusters contributed to by both cell lines. None of theStem Cell Reports j Vol. 14 j 406–419 j March 10, 2020 411
Figure 5. scRNA-Seq Reveals a Unique Pop-
ulation of Cells Only in the Adult HD Sample
(A) t-SNE plot of the aggregated scRNA-seq
data from both the control (18Q) and HD
(53Q) samples showing seven cell clusters.
Clusters were annotated using known cell-
type marker genes and are: mature neuron
(blue; TPD52 like 1 [TPD52L1], myocyte
enhancer factor 2C [MEF2C], paired box 6
[PAX6], and SIX homeobox 3 [SIX3]); D1 and
D2+ spiny neurons (orange; Meis homeobox 2
[MEIS2], distal-less homeobox 5 [DLX5], hip-
pocalcin [HPCA]); NSC cluster (green; nestin
[NES], cyclin D1 [CCND1]); D1+ spiny and
cholinergic striatal neurons (red; DLX5, ISL
LIM homeobox 1 [ISL1], Rac family small
GTPase 3 [RAC3], arginase 2 [ARG2]); D1+
spiny neurons (purple; MEIS2, protein phos-
phatase 1 regulatory inhibitor subunit 1A
[PPP1R1A], CaM kinase-like vesicle associated
[CAMKV], RAC3, glutamate ionotropic receptor
NMDA type subunit 2B [GRIN2B]); neural
progenitor cells (NPCs) (brown; CCND1, homer
scaffold protein 3 [HOMER3], EBF transcrip-
tion factor 1 [EBF1]); and immature neurons
(pink; VGF nerve growth factor inducible
[VGF], H1 histone family member 0 [H1F0]).
(B) Stacked violin plot showing expression of
glial, neural, and neuronal cell-type markers.
CCND1 expression is mainly visible in the NSC
cluster, which only exists in the HD (53Q)
sample.clusters express the astrocyte marker S100 calcium-binding
protein b (S100b) or glial fibrillary acidic protein (GFAP),
and most clusters express the neuronal marker MAP2,
with the neural progenitor marker NES only expressed in
the green and brown clusters. Only the NSC cluster in the
HD line had high levels of CCND1. CCND1 identifies the
aberrant HD population, and we find that other genes are
also upregulated in this cluster that are either lowly or
not expressed in the other six clusters (Table S2, columns
Q–V), including the progenitor marker NES and SRY-box
transcription factor 2 (SOX2), which identifies these cells
as an NSC-type population.
While the signal from the NSCs likely obscured gene
expression differences from the neuronal population in
our bulk RNA-seq dataset, scRNA-seq allowed for the iden-
tification of gene expression differences in MAP2+, NES/
SOX2 neurons between HD and control lines (Table S2,
columns W–AB). In this population, genes known to be
dysregulated in HD were observed, some of which are: ac-
tivity-regulated cytoskeleton associated protein (ARC), Fos
proto-oncogene, AP-1 transcription factor subunit (FOS),
JunB proto-oncogene, AP-1 transcription factor subunit412 Stem Cell Reports j Vol. 14 j 406–419 j March 10, 2020(JUNB), neuronal PAS domain protein 4 (NPAS4), and neu-
rogranin (NRGN), suggesting the possibility that these pop-
ulations contribute to previously defined HD molecular
signatures.
Inhibition of the WNT Signaling Pathway Abrogates
NSC Populations in HD Neuronal Cultures
Two of the top three transcriptional regulators with the
largest changes in RNA-seq expression are transcriptionally
regulated by WNT signaling: Oct4 (POU5f1, 6.479-fold
increase) and CCND1 (5.186-fold increase). Analysis of
TF-binding sites demonstrates that two of the top four reg-
ulatorymotifs near genes upregulated in both RNA-seq and
ChIP-seq are MYC and E2F, which are both involved with
WNT signaling (Hughes and Brady, 2005; Shi et al., 2015;
Yeo et al., 2011) (Figure 3E). Examination of the WNT/
b-catenin signaling pathway reveals significant dysregula-
tion of several key members, including components
of the b-catenin destruction complex, APC regulator
of WNT signaling pathway (APC), and glycogen
synthase kinase 3b (GSK3b) downregulated in HD lines
(Figure 6A). Additionally, scRNA-seq demonstrates that
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Figure 6. WNT/b-Catenin Signaling Is Significantly Dysregulated and WNT Inhibition Rescues Aberrant Cyclin D1 Overexpression
while Abrogating the Mitotic Population of Cells in Adult-Onset Neurons
(A) Dysregulation of the WNT/b-catenin signaling pathway from bulk RNA-seq was analyzed using Ingenuity Pathway Analysis. While
Frizzled receptors are upregulated, members of the b-catenin destruction complex, specifically APC and GSK3b, are downregulated, al-
lowing for upregulation of WNT/b-catenin transcriptional targets, such as CCND1 and Oct4 (POU5F1). Orange molecules are upregulated,
blue are downregulated, and black are targeted for destruction. A full legend can be found in Figure S5. 46Q and 53Q lines were compared
with controls with 18Q (2 clones), 28Q, and 33Q in triplicate using a 0.1 FDR.
(B) Dot plots show expression of WNT/b-catenin pathway genes and CCND1. The NSC cluster shows higher expression of all WNT-related
genes except for genes of the destruction complex, APC and GSK3b, and WNT7A, which shows higher expression in the NSC cluster over all
other clusters besides the cortical cluster.
(C) The WNT inhibitor ICG or DMSO was added to the NPC population at day 16 of differentiation. Cells were harvested at day 37 and western
blots were performed for cyclin D1, MAP-2, synaptophysin, and PSD95 using LI-COR.
(D) Quantitation demonstrates that treatment with ICG completely rescues aberrant overexpression of cyclin D1 in adult-onset striatal
neurons (50Q and 53Q). For analysis, lines were grouped by genotype. White bars represent DMSO-treated cells and black bars represent
ICG-treated cells. Analysis was done using a two-way ANOVA with Bonferroni correction. Multiplicity-adjusted p values were calculated for
each comparison at a 95% confidence interval. Data represent mean ± SEM. ****p < 0.0001. Data are from two independent experiments
using four cell lines grouped by control (18Q, 20Q) and HD (50Q, 53Q). Further statistical details can be found in Tables S3 and S4.
(E) Representative phase images show the mitotic population of cells at day 37 in adult-onset line (53Q) treated with DMSO (top-right
panel), which is completely abrogated by ICG addition (bottom-right panel). The 53Q line is a representative adult-onset line. Scale bar,
100 mm.the dysregulation we observe in the WNT/b-catenin
signaling pathway from the bulk analysis resides in the
NSC population, which has increased expression of Wing-
less-Type MMTV Integration Site Family, Member 7A(WNT7A), increased expression of Transcription Factor 3
(TCF3), increased expression of frizzled transcripts (frizzled
class receptor 2 [FZD2] and frizzled class receptor 7 [FZD7]),
decreased expression of b-catenin destruction complexStem Cell Reports j Vol. 14 j 406–419 j March 10, 2020 413
transcripts (APC and GSK3b), and increased expression of
WNT transcriptional targets (CCND1) (Figure 6B). We
were unable to detect POU5f1 expression in many of the
HD cells (about 90 positive cells in HD lines and three pos-
itive cells in controls), presumably due to lower sequencing
depth using the scRNA-seq platform.
Because of the regulatory role of WNT/b-catenin over
the expression of mitotic and pluripotency genes, we hy-
pothesized that downstream correction of the WNT/
b-catenin signaling pathway might reduce the mitotic
cues necessary for the persistence of the NSC population
in HD lines. Therefore, we titrated several WNT inhibi-
tors that act downstream of the b-catenin destruction
complex and found that the addition of ICG-001 (here-
after ICG) eliminates the mitotic cell population within
HD neuronal cultures. ICG is a selective, potent inhibitor
of b-catenin-mediated transcription by preventing the
interaction between CREB-binding protein and b-catenin
(Emami et al., 2004). ICG addition at day 16 in the differ-
entiation protocol significantly reduced cyclin D1 pro-
tein expression in HD lines (50Q, 53Q) by a factor of
10 (Figures 6C and 6D). A highly expanded repeat line
(109Q) was assessed to determine the potential effect of
ICG based on polyQ length; however, no additional ef-
fect was observed (Figure S6). Representative phase-
contrast images of a representative adult-onset line
(53Q; Figure 6E) demonstrate that ICG treatment abro-
gates the morphologically distinct NSC populations
within adult-onset HD neuronal cultures. Additionally,
ICG does not alter MAP-2 expression (Figure S6A), sug-
gesting that the presence of neurons is not altered by
treatment. While expression of synaptophysin and Disks
Large MAGUK Scaffold Protein 4 (alias PSD95) remain
unchanged in HD lines (Figures S6B and S6C), expression
of both is reduced in control lines by ICG treatment (Fig-
ure S6B). Notably, for these differentiations the 50Q line
overwhelmingly had the highest percentage of mitotic
cells and therefore, correspondingly, DMSO-treated 50Q
cells have the lowest levels of MAP-2, PSD95, and synap-
tophysin overall.DISCUSSION
Multi-omics-level analyses were performed on HD
neuronal cultures enriched for MSNs using a protocol
that induces increased expression of LGE markers
including distal-less homeobox 1 and 2 (DLX1/2) and GS
homeobox 2 (GSX2) mRNA. This response is likely via up-
regulation of BCL-11B, which is important for MSN devel-
opment (Arlotta et al., 2008). Introduction of activin A
increased co-localization of BCL-11B and DARPP-32+ neu-
rons, which is more indicative of MSNs than DARPP-32414 Stem Cell Reports j Vol. 14 j 406–419 j March 10, 2020positivity alone (Carri et al., 2013). Total RNA-seq and
scRNA-seq showed that the primary transcriptional differ-
ences were reflected in a persistent population of NSCs
within terminally differentiated, post-mitotic neuronal
cultures from patients with adult-onset repeats. These find-
ings are consistent with mitotic aberrations found in HD
iPSCs differentiated toward a striatal lineage (Mattis et al.,
2014). Here, we uncover a key mechanism underlying
this mitotic persistence.
mHTT has an impact on neurogenesis in HD knockin
(Molero et al., 2009), transgenic R6/1 (Lazic et al., 2004),
and R6/2 (Phillips et al., 2005) mouse models, and patient
postmortem tissue (Curtis et al., 2003, 2005). Neurodeve-
lopmental changes associated with mHTT expression are
observed in other stem cell-derived models: HTT-null
NSCs derived from mouse ESCs (Lo Sardo et al., 2012),
HD patient-derived iPSC striatal cells (Conforti et al.,
2018), and an isogenic allelic series of human ESCs differ-
entiated toward a cortical neuron fate form disorganized
neural rosettes (Ruzo et al., 2018), suggesting HD-related
aberrations during development of the neural tube. While
technical limitations of scRNA-seq limit analysis of Oct4
transcript abundance specifically within the NSC popula-
tion, our observation of Oct4 persistence by bulk RNA-seq
is corroborated by persistent Oct4 expression found in
neuronal differentiations (Conforti et al., 2018). Expres-
sion of mHTT impairs Oct4 protein downregulation even
in highly expanded repeat lines (60Q, 109Q, 180Q) during
differentiation when control cultures transition from plu-
ripotency to neuroectoderm formation. Aberrant mainte-
nance of Oct4 expression in ESC-derived neuronal cultures
has also been noted with expanded CAG repeats in other
contexts, for example within the hypoxanthine phosphor-
ibosyltransferase (Hprt) gene (Lorincz et al., 2004). Tempo-
ral dysregulation of other developmental markers has also
been observed; juvenile HD iPSCs differentiated toward a
striatal fate maintain nestin+ NPCs susceptible to death
by brain-derived neurotrophic factor withdrawal, suggest-
ing that mitotically persistent populations of cells are
vulnerable to factors mimicking the HD environment
(Mattis et al., 2014). These nestin+ NPCs were reduced by
targeting the canonical Notch signaling pathway and
lowering HTT by antisense oligonucleotide treatment
(Mathkar et al., 2019). Additionally, transcriptomic anal-
ysis of HD iPSC isogenic lines showed that differences
related to neuronal development and dorsal striatum for-
mation occur at the NSC stage (Ring et al., 2015), further
implicating the NSC stage in manifestation of develop-
mental aberrations due tomHTTexpression. In HD patient
iPSC-derived neural cultures, one-third of all gene expres-
sion changes were related to pathways involved in
neuronal development and maturation (HD iPSC Con-
sortium, 2017).
Several studies have implicated mitotic persistence in
altered neurogenesis in HD (Agus et al., 2019; Ooi et al.,
2019). ESC-isogenic HD lines differentiated into forebrain
neuronal cultures showed altered transcriptional signa-
tures for cell-cycle progression. Other studies implicated
cell-cycle re-entry as a mechanism of mitotic dysregulation
in HD (Ditsworth et al., 2017; Liu et al., 2015; Pelegrı´ et al.,
2008) and other neurodegenerative diseases (Ho¨glinger
et al., 2007; Seward et al., 2013). In contrast, our data indi-
cate a failure to exit the cell cycle as the primary mecha-
nism of persistent mitosis. It is possible that rare cells
persist randomly and give rise to a proliferating population
during differentiation as opposed to a specific mHTT-medi-
ated effect; however, this is unlikely given that this persis-
tent mitotic population is only observed in the adult-onset
lines, not control lines, and is present in all adult-onset
lines tested (n = 4). Furthermore, scRNA-seq data showed
no clusters having significant differentially expressed levels
of CCND1 between HD and control cells that also showed
high levels of mature neuronal marker expression, which
would be expected if mature neurons were re-entering the
cell cycle.
The work presented offers a mechanism for mitotic
persistence, aberrant WNT signaling leading to propaga-
tion of mitotic cell populations. This prolonged mitotic
state may underlie the transient excess neurogenesis
observed in animal models of HD and patient adult stria-
tum (Curtis et al., 2003; Ernst et al., 2014; Tattersfield
et al., 2004). Altered WNT signaling is implicated in HD
pathogenesis. b-Catenin pathway modulation rescued the
toxic effects of mHTT expression and increased the life
span in HD Drosophila, attenuated neurodegeneration of
primary striatal neurons (Godin et al., 2010), andWNTdys-
regulation may promote aberrant angiogenesis-related
signaling observed in HD iPSC-brain microvascular endo-
thelial cells (Lim et al., 2017), suggesting that this pathway
may be critical in understanding primary mechanisms
affected as a consequence of chronic mHTT expression.
While HTT interacts with the b-catenin destruction com-
plex in vitro and in vivo, the expanded polyQ region in
mHTT prevents binding, leading to toxic b-catenin stabili-
zation and eventual neurodegeneration (Godin et al.,
2010). One possibility for the presence of the NSC popula-
tion only in adult-onset and not in juvenile-range repeat
HD neuronal cultures is a threshold activation of the
WNT pathway controlled by polyQ length. In neurons,
highly expanded polyQ lengths may cause structural
changes different from those observed in adult-onset cases
that further dysregulate protein-protein interactions and
downstream signaling (Caron et al., 2013) such that the
highly expanded polyQ region no longer prevents b-cate-
nin from binding the destruction complex and allows for
b-catenin degradation, thus preventing transcription ofWNT targets such as CCND1 and Oct4. This could allow ju-
venile lines to follow the same developmental paradigm as
control lines without the presence of aberrant NSCs in
neuronal populations.
Many neuronal induction protocols exploit inhibition of
the WNT pathway due to its role in determining neural
crest cell fate (Menendez et al., 2011); two striatal differen-
tiation protocols add the WNT inhibitor DKK1 after initial
neural induction (Aubry et al., 2008; Delli Carri et al.,
2013). Consistent with the hypothesis that WNT may be
differentially activated in the adult-onset versus juvenile-
repeat striatal-enriched neuronal cultures, RNA-seq
showed that b-catenin destruction complex members
were downregulated in adult-onset lines compared with
similar levels of both APC and GSK3b in control and juve-
nile lines (data not shown). With the addition of
CHIR99021, the WNT agonist, in our protocol, the adult-
onset lines may no longer be able to compensate for the
overactivation of WNT, thereby uncovering a previously
undefined mechanism.
We expected to uncover myriad cell-intrinsic differences
between control and juvenile HD neuronal cultures and
were surprised to find few transcriptional differences.
This may be informative for the neurodegenerative disease
field in the context of pure populations of iPSC-derived cell
types to investigate cell-intrinsic effects. Furthermore,
these findings perhaps highlight the phenotypic differ-
ences observed between adult- and juvenile-repeat HD,
which present quite differently, with manifestation of
dyskinesia and global neurodegeneration observed in juve-
nile cases not present with adult onset (Ruocco et al., 2006).
We do not know whether the lack of transcriptional differ-
ences between control and juvenile groups is a conse-
quence of (1) juvenile-repeat cell cultures bypassing some
point in the differentiation process, (2) cells within the ju-
venile-repeat lines that remain as NSCs being highly sus-
ceptible to cell death, (3) the length of the polyQ repeat
expansion acting as flexible domain that modulates the
spatial proximity of N17 and polyproline-flanking do-
mains, thereby affecting downstream signaling (Caron
et al., 2013), or (4) the need for signals from other cell types
for full manifestation of disease. However, regarding point
(4), scRNA-seq data fromMAP2+,NES/SOX2neurons iden-
tifies genes known to be dysregulated in HD neurons, sug-
gesting that there are HD signatures in adult-onset iPSC-
derived neurons that overlap with previously published
data (HD iPSC Consortium, 2017). The protocol used
here reflects very early cell-intrinsic effects. Thus far, we
have observed the mitotic population of cells in all adult-
onset lines differentiated with this protocol, but only rarely
in juvenile-repeat lines and never in control lines.
Overall, our data show that there is a persistent, mitoti-
cally active cell population unique to adult-onset repeatStem Cell Reports j Vol. 14 j 406–419 j March 10, 2020 415
HD cell lines that we can prevent in vitro by targeting the
WNT pathway with the application of the WNT inhibitor
ICG. While ICG is used as a tool to demonstrate the mech-
anism behind the persistence of NSCs in the context of HD,
we speculate that specific components of the WNT
signaling pathway inhibited by ICG could be therapeutic
targets for HD with the potential to compensate for neuro-
developmental defects.EXPERIMENTAL PROCEDURES
Products were purchased from Thermo Fisher Scientific (Waltham,
MA, USA), unless stated. See Supplemental Information for addi-
tional experimental procedures and buffer formulations.
iPSC Differentiation
iPSC lines were generated as described by HD iPSC Consortium
(2017). iPSCs were cultured on hESC-qualified Matrigel (Corn-
ing) in mTESR1 (STEMCELL Technologies) and passaged
with Versene (Gibco). At 60%–70% confluency, medium
was changed to start neural differentiation as described by Tele-
zhkin et al. (2016) However, at day 8 cells were replated in acti-
vin A-containing medium (see Supplemental Experimental
Procedures).
Immunofluorescence
Cells grown on glass coverslips were fixed with 4% paraformalde-
hyde (PFA; Electron Microscopy Sciences) in PBS for 10 min. Anti-
body incubations and imaging are described in Supplemental
Experimental Procedures.
RNA-Seq
Total RNA was isolated using the Qiagen RNeasy Kit and
QIAshredders for cell lysis. Onemicrogramof RNAwith RNA integ-
rity number values >9 were used for library preparation using the
strand-specific Illumina TruSeq Total RNA protocol. Libraries
were sequenced on the HiSeq 2500 platform using 100 cycles to
obtain paired-end 100 reads at >50 million reads per sample.
scRNA-Seq
Samples for scRNA-seq were harvested using Dispase (Gibco) for
30 min at 37C, pipetted off the plate with advanced DMEM/F12
(1:1) with 2% B27, and collected by centrifugation. Cells in 0.1%
BSA PBS were filtered through a 70-mm cell strainer and counted.
Cells were resuspended at 700 cells/mL in 0.04% BSA in PBS at
>80% viability.
ChIP-Seq
Frozen cell pellets (minimum of two replicates per line) were
resuspended in lysis buffer and incubated on ice for 20 min.
Chromatin was digested and samples processed as described in
Supplemental Experimental Procedures. Libraries were prepared
using NEBNExt Ultra II DNA Library Prep Kit for Illumina (NEB)
and sequenced on an Illumina HiSeq 2000 for single-end 50-bp
reads.416 Stem Cell Reports j Vol. 14 j 406–419 j March 10, 2020ATAC-Seq
Cryostored cell samples were processed in duplicates as previously
described (Milani et al., 2016). The ATAC-seq libraries were
sequenced on an Illumina HiSeq 2000 for single-end 50-bp reads.
Data Processing
For RNA-seq, fastq files were trimmed using a base quality score
threshold of >20 and aligned to the hg19 genome with TopHat
2. Reads passing quality control were used for quantification using
HTSeq and analyzed with the R package DESeq2 to identify DEGs.
Genes passing an FDR of 10% were used for GO enrichment anal-
ysis using GOrilla (Eden et al., 2007, 2009) (http://cbl-gorilla.cs.
technion.ac.il/).
For scRNA-seq, fastq files were quality controlled and aligned to
the reference transcriptome to obtain a gene count matrix. Before
downstream tertiary analysis, quality control of cells was per-
formed by filtering out low-quality cells and low-abundance genes.
After quality control and expression matrix formation, normaliza-
tion was performed using UMI (unique molecular identifiers), and
log transformationwas used to control variance. Dimension reduc-
tionwas used to visualize and exploremajor features of the data us-
ing PCA and t-SNE, and differential expression statistical analyses
were performed using Seurat and Scanpy. Cell types were assigned
based on known cell-type markers.
For ChIP-seq, fastq files were aligned to the hg38 genome assem-
bly using Bowtie2. The ENCODE blacklist regions and PCR dupli-
cates were removed (using SAMtools and Picard). Peak calling
was done using MACS2 (–broad flag, q-value < 0.1). Differential
analysis of the peaks was performed with Diffbind (Ross-Innes
et al., 2012) (http://bioconductor.org/packages/DiffBind/), using
EdgeR with FDR <0.05. Differential peaks were annotated to genes
within a window of 10 kb from the TSS. GO enrichment analysis
was done using Panther (Mi et al., 2012; Thomas et al., 2003)
(http://pantherdb.org/webservices/go/overrep.jsp).
For ATAC-seq, fastq files were aligned to hg38 genome assembly
using Bowtie2. ENCODE blacklist regions and PCR duplicates were
removed (using SAMtools and Picard). Peak calling was done using
MACS2 (–nomodel –shift100 –extsize 200 settings and q-value <
0.05). The consensus peak file for all samples was generated using
Diffbind.
Motif Analysis
HOMER (v.4.9.1) was used to identify TF motifs that are enriched
in the differential ChIP-seq peaks. ATAC-seq data were used to
identify TF-binding locations; thus, for motif analysis we consid-
ered consensus ATAC-seq peaks that overlap with the aforemen-
tioned differential ChIP-seq peaks. To identify enriched motifs,
we used the findMotifs function in HOMER with default parame-
ters; we looked for motif enrichment in the consensus ATAC-seq
peaks within ChIP-seq differential peaks compared with a back-
ground of all consensus ATAC-seq peaks that are within 10 kb of
the TSS of any gene.
Flow Cytometry
Neuronal cultureswere harvested at day 37 andfixed in suspension
with 4% PFA. Aliquots of cells were made for FMO (Fluorescence
Minus One) and unstained controls pooled from all samples
incubated for 2 h at room temperature with primary antibody,
washed three times, and incubated with secondary antibody for
30 min. Cells were washed and resuspended in FACS (fluores-
cence-activated cell sorting) buffer, pipetted through a cell strainer
(Falcon), and run on a BD LSRII flow-cytometry machine. Gating
was performed using BD FACSDiva software. Further analysis was
performed using De Novo FCS Express 6.
Western Blotting
Cells for western blots were scraped and harvested in cold
PBS-Mg2+/-Ca2+ and flash frozen until processing. Analysis was
performed using the LI-COR Odyssey CLx imaging system (see
Supplemental Experimental Procedures).
Statistical Analysis
Error bars represent the mean ± SEM where stated. One-tailed t
tests were used for comparison of two groups of data. For dataset
comparisons of three or more, one-way ANOVA was used; for
comparing datasets with two variables among multiple samples,
two-way ANOVA was used as stated. Statistical analyses were per-
formed using GraphPad Prism v.8 using p < 0.05 as significant.
Further information from statistical tests not in figure legends
can be found in Tables S3 and S4. For specific assay statistical infor-
mation, see Supplemental Experimental Procedures.
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All data and code are available from the corresponding authors
upon reasonable request. The accession codes are: ChIP-seq,
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